Hooper Holmes Inc (HH)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Hooper Holmes Inc (HH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013440
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hooper Holmes Inc (Hooper Holmes) is a provider of health and screening services. The company provides health services such as individual screenings at home or work, onsite screenings for small and large companies, remote screenings for individuals and eligible family members, convenient walk-in local retail clinics for blood tests, at home collection kits from our clinical lab partner, our own physician fax record retrieval service, and specimen collection and testing. It offers biometric screening services that include finger-stick or venipuncture blood draw, full lipid profile and blood glucose, blood pressure and pulse, body mass index, notification of out of range biometric values, and biometric results review and reporting. The company offers its services to employers and health insurance providers. Hooper Holmes is headquartered in Olathe, Kansas, the US.

Hooper Holmes Inc (HH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hooper Holmes Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Hooper Holmes Acquires Assets of Health and Wellness Business from Accountable Health Solutions for USD7 Million 9
Asset Transactions 10
Hooper Holmes Acquires Assets of Health and Wellness Business from Accountable Health Solutions for USD7 Million 10
Clinical Reference Acquires Assets from Hooper Holmes for USD3.5 Million 11
American Para Professional Systems Completes Acquisition Of Portamedic Brand and Paramedical Exam Service Line Of Hooper Holmes For US$8.4 Million 12
Hooper Holmes Inc – Key Competitors 14
Hooper Holmes Inc – Key Employees 15
Hooper Holmes Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Jul 06, 2016: Hooper Holmes Expands Health & Wellness Services 17
Financial Announcements 18
Nov 09, 2017: Hooper Holmes Announces Third Quarter 2017 Financial Results 18
Aug 10, 2017: Hooper Holmes Announces Second Quarter 2017 Financial Results 19
May 12, 2017: Hooper Holmes Announces First Quarter 2017 Financial Results 20
Nov 10, 2016: Hooper Holmes Announces Third Quarter 2016 Financial Results 21
Aug 11, 2016: Hooper Holmes Announces Second Quarter 2016 Financial Results 22
May 12, 2016: Hooper Holmes Announces First Quarter 2016 Financial Results 23
Apr 06, 2016: Hooper Holmes Issues Corporate Update 24
Mar 29, 2016: Hooper Holmes Announces 2015 Financial Results 25
Corporate Communications 26
Mar 16, 2017: Dr. Robin Smith Joins Hooper Holmes as a Board Advisor 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hooper Holmes Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hooper Holmes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Hooper Holmes Acquires Assets of Health and Wellness Business from Accountable Health Solutions for USD7 Million 9
Hooper Holmes Acquires Assets of Health and Wellness Business from Accountable Health Solutions for USD7 Million 10
Clinical Reference Acquires Assets from Hooper Holmes for USD3.5 Million 11
American Para Professional Systems Completes Acquisition Of Portamedic Brand and Paramedical Exam Service Line Of Hooper Holmes For US$8.4 Million 12
Hooper Holmes Inc, Key Competitors 14
Hooper Holmes Inc, Key Employees 15
Hooper Holmes Inc, Subsidiaries 16

★海外企業調査レポート[Hooper Holmes Inc (HH)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujirebio Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Fujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company which manufactures and exports reagents and equipments for clinical diagnostics and assay systems. The company’s products include serodia series, automated analyzer system and MSDS, among others. Fuji …
  • Lijun International Pharmaceutical (Holding) Co., Ltd. (2005):企業概要、財務及び戦略的SWOT分析
    Summary Lijun International Pharmaceutical (Holding) Co., Ltd. (Lijun) is a pharmaceutical company. The company develops, manufactures and markets pharmaceutical products for healthcare markets. Its products include antibiotics, intravenous infusion solution, non-antibiotics finished medicines, bulk …
  • GAZ (GAZA):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "GAZ" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardize …
  • USG People N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' USG People N.V. Mergers and Acq …
  • Aqua Terrena International AB:企業の戦略・SWOT・財務分析
    SummaryAqua Terrena International AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • YaSheng Group Ltd. (HERB):企業の財務及び戦略的SWOT分析
    Summary YaSheng Group Ltd. (YaSheng), a subsidiary of Gansu Jinta Hengsheng Agricultural Development Co., Ltd. is an agriculture product provider that offers specialty agriculture based products. The company offers products such as peaches, and saplings, durum wheat, cotton, cotton processing, hemp, …
  • Particle Sciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Particle Sciences, Inc. Mergers …
  • Falck Renewables S.p.A. (FKR):企業のM&A・提携動向(エネルギー分野)
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly known as Actelios S.p.A., is a Milan based renewable energy company. It is a subsidiary of Falck S.p.A. It develops designs, constructs and manages energy production plants for contributing people’s energy requirement. It produces wind ene …
  • Kura Oncology Inc (KURA):企業財務及び戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogenes or signaling pathways that drive cancer …
  • Dr. Honle AG (HNL):企業の財務及び戦略的SWOT分析
    Summary Dr. Honle AG (Honle) is an industrial equipment company that provides UV products. The company offers products such as UV equipments and UV systems; UV measurement systems, LED units, UV lamps, electronic power supplies, UV strip and UV scan systems, and UV adhesives. Its UV measurement syst …
  • Pure Bioscience, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pure Bioscience, Inc. Mergers a …
  • Singapore Technologies Electronics Ltd:企業の戦略・SWOT・財務情報
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Strata Oil & Gas Inc. (SOIGF):企業財務及び戦略的SWOT分析
    Summary Strata Oil & Gas Inc. (Strata Oil & Gas) a subsidiary of Royal Dutch Shell plc is an oil and gas company that explores and develops bitumen from carbonates. The company owns and operates two main projects which include Cadotte Central and Cadotte West. Its Cadotte Project is in the Grosmont …
  • Panhandle Oil and Gas Inc (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • China Oilfield Services Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Oilfield Services Limited …
  • medac GmbH(製薬・医療分野):企業M&A動向
    Summary Medac GmbH (Medac) is a pharmaceutical company. It carries out both diagnostics and therapeutics of diseases caused by viruses, bacteria, fungi, or parasites. The company through its diagnostics division, , develops, produces and markets in vitro diagnostics (IVD) devices. Medac therapeutic …
  • David Lloyd Leisure Ltd:企業の戦略・SWOT・財務分析
    SummaryDavid Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Veolia Water Solutions and Technologies:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Veolia Water Solutions and Tech …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • BlueNRGY Group Limited (CBDE):企業のM&A・提携動向(エネルギー分野)
    Summary BlueNRGY Group Limited (BlueNRGY), formerly known as CBD Energy Limited, is a diversified renewable energy company. The company offers engineered systems and solutions for distributed power generation, climate control and energy efficiency. It designs, installs and maintains renewable energy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆